Search your discard pile for a Supporter card and use the effect of that card as the effect of this attack. (The Supporter card remains in your discard pile.)
Choose 1 of your opponent's Pokémon. This attack does 40 damage to that Pokémon. This attack's damage isn't affected by Weakness or Resistance.
Release year for POP Series 7 is 2008. It belongs to the POP series.
The checklist contains 17 cards, placing it in a compact expansion range. As of 2026, the set is 18 years old and fits a legacy-era profile.
Kirlia (#8) is one of the Uncommon prints in this expansion.
Kirlia is a POP Series 7 card from the 2008 release window. The printed flavor text states: "It is highly perceptive of its Trainer's feelings.
It dances when it is feeling happy." Its card type is Pokémon. The rarity label is Uncommon.
Printed HP is 80. Energy typing is Psychic.
This gives collectors a clear identity footprint for the print. This card evolves from Ralts.
Kirlia from POP Series 7 is currently trading around $7.21. Week-over-week change is limited (0.0%), indicating short-term stability.
That is close to the 30-day average of $7.21. The 90-day window shows a floor near $6.76 and a peak around $7.59 (12% total spread), which maps to low-volatility movement.
Rarity classification for this copy is Uncommon.
A wider Kirlia checklist helps contextualize this specific Kirlia print. The current sample spans 6 comparable cards from 6 sets.
Observed alternatives run from $0.15 to $27.78 (18420% spread). The current card sits +49% versus the sampled alternative average of $4.84.
Notable alternatives include Kirlia #88 (Ascended Heroes) at $0.18, Kirlia #69 (BREAKthrough) at $0.33, Kirlia #53 (Ancient Origins) at $0.42, and Kirlia #SWSH271 (SWSH Black Star Promos) at $27.78.
Current valuation lens: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. Observed 90-day bounds of $6.76 and $7.59 create a 12% band, matching a low-volatility profile.
Current value remains close to its 30-day mean ($7.21). Graded comparison currently centers on PSA 9 near $35.00, representing +385% over raw value.
